ArticleFrontiers in medicine2026
Case Report: Neuronal intranuclear inclusion disease mimicking recurrent stroke in the setting of intracranial stenosis.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neuronal intranuclear inclusion disease (NIID) is a rare, progressive neurodegenerative disorder that can present with stroke-like episodes, posing a significant diagnostic challenge. This difficulty is compounded when it coincides with intracranial atherosclerotic stenosis, a common cause of recurrent stroke. Case presentation: We report the case of a 64-years-old woman without conventional vascular risk factors who presented with a recurrent acute focal neurological deficit-her sixth similar episode over 8 years, each previously diagnosed as cerebral infarction. Brain magnetic resonance imaging (MRI) revealed a new area of restricted diffusion in the right frontoparietal region and an ipsilateral middle cerebral artery (MCA) M2 segment stenosis (>50%). Crucially, a systematic review of the diffusion-weighted imaging (DWI) sequences identified the pathognomonic linear hyperintensity along the corticomedullary junction, known as the "ribbon sign," which is highly suggestive of NIID. Despite a negative genetic test for the NOTCH2NLC GGC repeat expansion, the diagnosis was confirmed by a minimally invasive skin biopsy, which demonstrated characteristic non-membranous intranuclear inclusions on electron microscopy. Conclusion: We highlight the imperative to recognize this specific and pathognomonic neuroimaging pattern even in the presence of coincidental atherosclerosis. Furthermore, we detail the systematic diagnostic approach when genetic testing is unrevealing, emphasizing the pivotal role of targeted tissue biopsy in achieving a definitive diagnosis. This report underscores the key learning points in evaluating acute stroke mimics with atypical evolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.